Top section
Top section
◆ Fast money reverses out of SSA bond market ◆ CLO managers face risky ramp startegy ◆ Corporate hybrid bond market runs hot despite volatility
◆ French pharma prints along liquid parts of the curve ◆ Two shorter tranches land flat to fair value ◆ Danaher showed demand for high rated issuers earlier in the week
◆ Safer credits prove popular in uncertain market ◆ Alliander sheds orders as it punches through fair value ◆ Argan ends near five year euro absence
Data
More articles
More articles
More articles
-
In an age of abundant information and opinion, where much of it is wrong, smart investment bankers can still be valuable to clients by embracing the complexity -
The subordinated debt premium was smaller than that offered by some other EM hybrid issuers
-
At London investor day, supranational reveals deals and plans for new funding and investments, including fully African project financing
-
Bot claims funding is ‘cheaper than peers who borrow from independent banks or credit funds’
-
Third Canadian province to come to the currency this year
-
Investors maintain orders as issuers push tight, although some limits are appearing
Sub-sections
